Celldex Therapeutics to Present at the Leerink Partners Immuno-Oncology Roundtable
September 30 2015 - 3:35PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
Anthony Marucci, Co-founder, President and Chief Executive Officer,
and Thomas Davis, M.D., Executive Vice President and Chief Medical
Officer, will participate in a fireside chat at the Leerink
Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015 at
1:05 p.m. EDT in New York City.
The live webcast of the presentation will be available on the
"Events & Presentations" page of the "Investors & Media"
section of the Celldex website. A replay of the presentation will
be available for seven days following the event.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline is built from a proprietary portfolio of antibodies
and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or
suppress the body's immune response. Visit www.celldex.com.
CONTACT: Sarah Cavanaugh,
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Sep 2023 to Sep 2024